BEAM's logo.
Ticker Symbol: BEAM

Beam Therapeutics Inc

$90.00 - 02-12-2024 4 p.m. ET

Exchange: NASDAQ Currency: USD Asset Type: Common Stock CIK:0001745999

Company Profile

beam therapeutics is developing precision genetic medicines for serious diseases. co-founded by scientific pioneers known for advancing crispr gene editing, we’re the first company to pursue development of new therapies using crispr base editing technology. we aim to use these technologies to generate a broad pipeline of precision genetic medicines that repair disease-causing point mutations, write in protective genetic variations, or modulate the expression or function of disease-causing genes. who we are beam is creating precision genetic medicines through base editing why we do it our dream is to provide life-long cures for patients suffering from serious diseases who we are and how we work together the beam team:  a community of fearless innovators  rigorous and honest in our research  listening with open minds  committed to each other

Sector: Manufacturing
Industry: Biological Product (except Diagnostic) Manufacturing
Standard Industrial Classification Code (SIC code): 2836
Address: N/A
Website: beamtx.com
CEO: John M. Evans
Tags:
  • Health Technology
  • Biotechnology
  • Manufacturing
  • Biological Product (except Diagnostic) Manufacturing

Pricing

Last Updated: October 20, 2023 03:00 PM EST
Previous Close: $17.69
Change: -$0.67 ( -3.65%)
Days Range: $16.95 - $18.34
Beta: 1.87
52wk. High: $54.30
52wk. Low: $16.95
Ytd. Change -58.42%
50 Day Moving Average: $23.20
200 Day Moving Average: $28.71
Shares Outstanding: 79199501

Valuation

Market Cap: 140.1B
PE Ratio: -3.91
EPS (TTM): -4.52

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A